KRT88P and cancer: All cancer cells treated with ΔHBc particles showed very little increase in the fold increase in MFI, indicating a significant reduction in intracellular uptake of the truncated particles, supporting the hypothesis that the deletion of the arginine-rich domain can reduce the non-specific binding ability of WT-HBc particles.